YCBD RSI Chart
Last 7 days
5.9%
Last 30 days
-21.7%
Last 90 days
4.4%
Trailing 12 Months
-62.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 22.4M | 0 | 0 | 0 |
2023 | 30.1M | 27.7M | 25.1M | 24.2M |
2022 | 41.5M | 39.1M | 37.1M | 33.5M |
2021 | 48.6M | 49.2M | 47.3M | 44.1M |
2020 | 39.8M | 40.8M | 43.2M | 45.9M |
2019 | 14.3M | 21.2M | 28.1M | 37.8M |
2018 | 6.8M | 8.2M | 459.1K | 7.4M |
2017 | 4.0M | 4.7M | 5.4M | 5.7M |
2016 | 0 | 0 | 2.6M | 3.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 29, 2024 | swift sibyl nichole | acquired | - | - | 4,000 | - |
Mar 29, 2024 | stephen scott g. | acquired | - | - | 4,000 | - |
Mar 29, 2024 | raines william f iii | acquired | - | - | 4,000 | - |
Mar 29, 2024 | sellers bakari t. | acquired | - | - | 4,000 | - |
Jan 11, 2024 | coffman raymond scott | acquired | - | - | 13,011 | - |
May 03, 2023 | kennedy thomas ronan | bought | -10,500 | 2.1 | -5,000 | interim ceo and cfo |
Feb 17, 2023 | swift sibyl nichole | acquired | - | - | 5,000 | - |
Feb 17, 2023 | stephen scott g. | acquired | - | - | 5,000 | - |
Feb 17, 2023 | raines william f iii | acquired | - | - | 5,000 | - |
Feb 17, 2023 | sellers bakari t. | acquired | - | - | 5,000 | - |
Which funds bought or sold YCBD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Penserra Capital Management LLC | sold off | -100 | -12,000 | - | -% |
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | sold off | -100 | -1.00 | - | -% |
May 15, 2024 | CSS LLC/IL | unchanged | - | 9,523 | 61,602 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -55.26 | -1,000 | 1,000 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -1.33 | -9.00 | 69.00 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -74.07 | -1,310 | 580 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | -54.00 | 455 | -% |
May 14, 2024 | Farther Finance Advisors, LLC | unchanged | - | -8.00 | 36.00 | -% |
May 14, 2024 | HHM Wealth Advisors, LLC | unchanged | - | -7.00 | 63.00 | -% |
May 14, 2024 | Qube Research & Technologies Ltd | new | - | 279 | 279 | -% |
Unveiling cbdMD Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to cbdMD Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 372.2B | 85.6B | 9.67 | 4.35 | ||||
MRK | 332.3B | 61.4B | 144.1 | 5.41 | ||||
AMGN | 167.7B | 29.5B | 44.55 | 5.68 | ||||
PFE | 162.3B | 57.8B | 129.52 | 2.81 | ||||
GILD | 84.4B | 27.4B | 174.21 | 3.07 | ||||
TEVA | 18.4B | 16.0B | -37.29 | 1.15 | ||||
MID-CAP | ||||||||
ALKS | 4.1B | 1.7B | 9.41 | 2.37 | ||||
PRGO | 4.1B | 4.6B | -528.11 | 0.89 | ||||
BHC | 2.5B | 9.0B | -5.45 | 0.28 | ||||
AMPH | 2.1B | 676.2M | 13.75 | 3.14 | ||||
SMALL-CAP | ||||||||
TLRY | 1.5B | 743.2M | -4.35 | 2.06 | ||||
TXMD | 25.8M | 1.3M | -3.49 | 19.84 | ||||
ACRX | 18.4M | 89.6M | -1.29 | 0.19 | ||||
AGRX | 2.5M | 21.5M | -0.32 | 0.12 | ||||
ACOR | 633.5K | 115.7M | 0 | 0.01 |
cbdMD Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -10.4% | 4,816,444 | 5,375,630 | 5,765,701 | 6,462,965 | 6,584,666 | 6,240,526 | 8,448,497 | 8,868,093 | 9,948,858 | 9,856,767 | 10,390,168 | 11,352,585 | 12,457,386 | 13,131,946 | 12,247,100 | 10,809,387 | 9,703,800 | 10,412,491 | 9,908,777 | 9,734,459 | 7,752,478 |
Cost Of Revenue | -1.2% | 1,795,790 | 1,817,907 | 2,161,900 | 2,273,839 | 2,224,512 | 2,517,452 | 2,891,067 | 2,660,185 | 3,186,564 | 4,328,310 | 4,050,710 | 3,370,952 | 3,643,127 | 3,430,274 | 5,334,090 | 3,748,024 | 2,732,076 | 3,700,537 | 4,127,400 | 2,929,160 | 1,914,716 |
Gross Profit | -27.5% | 2,580,728 | 3,557,498 | 3,548,845 | 3,845,541 | 4,015,508 | 3,567,766 | 4,968,556 | 5,932,708 | 6,442,322 | 4,993,512 | 5,742,617 | 7,189,571 | 8,155,484 | 8,898,028 | 6,365,827 | 6,888,521 | 6,666,960 | 6,447,699 | 5,416,736 | 5,075,989 | 3,721,862 |
Operating Expenses | - | - | - | - | - | - | - | - | - | 11,452,700 | 11,955,284 | 12,755,319 | 13,865,191 | 12,323,207 | 10,657,973 | 10,896,900 | 8,226,029 | 12,267,637 | 12,560,297 | 10,627,860 | 11,542,628 | 5,749,463 |
EBITDA Margin | -17.2% | -0.95 | -0.81 | -0.90 | -0.76 | -1.69 | -1.62 | -1.86 | -1.47 | -0.58 | -0.74 | -0.49 | -0.52 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -4301.7% | -18,399 | -418 | 53,654 | -1,246 | -1,946 | 29,119 | 23,117 | -1,551 | -2,086 | -3,234 | -5,358 | -2,582 | -10,603 | -10,386 | -12,617 | 3,436 | 35,607 | 7,267 | 24,882 | 6,229 | 6,274 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | -462,000 | 103,000 | -536,000 | 332,000 | 1,345,300 | - | - | -2,240,300 | -63,000 | -1,088,000 | -1,075,000 |
Earnings Before Taxes | -202.1% | -3,010,562 | -996,501 | -15,874,940 | -1,770,404 | -1,336,802 | -3,956,062 | -14,630,917 | -31,634,143 | -4,657,215 | -19,160,904 | -3,156,081 | 1,640,288 | -13,046,474 | -9,727,621 | -5,363,561 | -8,944,921 | 14,883,772 | 10,730,665 | 14,249,202 | -28,021,178 | -32,925,877 |
EBT Margin | -16.9% | -0.97 | -0.83 | -0.92 | -0.78 | -1.71 | -1.64 | -1.89 | -1.50 | -0.61 | -0.77 | -0.51 | -0.54 | - | - | - | - | - | - | - | - | - |
Net Income | -202.1% | -3,010,562 | -996,501 | -15,874,941 | -1,770,404 | -1,336,802 | -3,956,062 | -14,631,432 | -31,634,143 | -4,657,216 | -19,160,904 | -3,026,082 | 1,537,288 | -12,510,474 | -9,395,621 | -6,258,562 | -8,952,702 | 14,883,772 | 12,929,763 | 11,884,544 | -29,202,956 | -31,850,274 |
Net Income Margin | -16.9% | -0.97 | -0.83 | -0.92 | -0.78 | -1.71 | -1.64 | -1.89 | -1.50 | -0.61 | -0.75 | -0.49 | -0.54 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -140.8% | -699,448 | -290,515 | -383,681 | -342,962 | -1,631,230 | -2,241,727 | -2,152,140 | -2,459,358 | -5,344,827 | -5,699,505 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -3.6% | 14,550 | 15,095 | 16,195 | 32,970 | 33,684 | 35,727 | 40,792 | 57,138 | 92,988 | 99,327 | 124,883 | 115,522 | 121,058 | 124,079 | 110,843 | 111,311 | 112,583 | 101,797 | 94,518 | 100,909 | 94,835 |
Current Assets | 0.6% | 7,410 | 7,366 | 8,070 | 10,091 | 10,146 | 11,529 | 16,012 | 19,858 | 24,327 | 29,679 | 36,502 | 29,983 | 34,746 | 37,375 | 23,712 | 24,112 | 24,885 | 14,874 | 15,743 | 22,186 | 14,144 |
Cash Equivalents | 39.9% | 2,105 | 1,505 | 1,798 | 2,847 | 1,719 | 3,353 | 6,720 | 9,554 | 13,337 | 19,697 | 26,411 | 18,984 | 23,712 | 28,764 | 14,825 | 15,006 | 14,836 | 3,661 | 4,690 | 11,633 | 4,640 |
Inventory | - | 3,452 | - | 4,236 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,116 | 2,065 |
Net PPE | -15.5% | 668 | 790 | 717 | 700 | 798 | 901 | 823 | 775 | 2,335 | 2,504 | 2,562 | 2,775 | 2,977 | 3,084 | 3,183 | 3,068 | 3,224 | 2,158 | 1,716 | 1,017 | 817 |
Goodwill | - | - | - | - | - | - | - | - | 11,996 | 42,773 | 56,671 | 56,671 | 54,670 | 54,670 | 54,670 | 54,670 | 54,670 | 54,670 | 54,670 | 54,670 | 55,134 | 55,144 |
Liabilities | 42.3% | 11,463 | 8,058 | 7,164 | 7,238 | 7,898 | 9,136 | 9,367 | 10,538 | 12,965 | 14,927 | 21,741 | 26,242 | 35,173 | 38,359 | 31,661 | 27,731 | 20,426 | 46,272 | 56,914 | 75,763 | 108,251 |
Current Liabilities | 16.2% | 6,937 | 5,972 | 4,670 | 4,384 | 4,679 | 5,552 | 5,286 | 5,725 | 5,785 | 6,761 | 6,917 | 6,750 | 6,864 | 6,737 | 7,689 | 4,386 | 5,792 | 5,481 | 3,710 | 2,330 | 1,871 |
Long Term Debt | - | - | - | 9* | 819* | - | - | 125 | 128 | 78.00 | 93.00 | 109 | 124 | - | - | 264 | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | 9* | 819* | - | - | 125 | 128 | 78.00 | 93.00 | 109 | 124 | - | - | 264 | - | - | - | - | - | - |
Shareholder's Equity | -56.1% | 3,087 | 7,037 | 9,031 | 25,732 | 25,786 | 26,591 | 31,424 | 46,600 | 80,023 | 84,400 | 103,142 | 89,280 | 85,885 | 85,720 | 79,182 | 83,580 | 92,158 | 55,524 | 37,604 | 25,146 | - |
Retained Earnings | -2.3% | -180,371 | -176,360 | -174,363 | -157,488 | -154,717 | -152,380 | -147,423 | -131,791 | -99,156 | -93,499 | -73,337 | -68,977 | -69,954 | -56,884 | -47,388 | -41,029 | -31,977 | -46,760 | -59,610 | -70,782 | -43,083 |
Additional Paid-In Capital | 0.0% | 183,457 | 183,390 | 183,387 | 183,212 | 180,497 | 178,905 | 178,842 | 178,327 | 179,116 | 177,836 | 176,417 | 158,198 | 155,780 | 142,549 | 126,518 | 124,558 | 124,083 | 102,257 | 97,187 | 96,130 | 28,383 |
Shares Outstanding | 2.8% | 3,045 | 2,961 | 2,961 | 2,855 | 1,457 | 1,341 | 1,348 | 1,316 | 1,313 | 1,285 | 1,284 | 1,259 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -229 | 1,274 |
Float | - | - | - | - | - | 12,718 | - | - | - | 42,426 | - | - | - | - | - | - | - | 30,947 | - | - | - | 42,357 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -565.0% | -704 | -105 | -263 | -240 | -1,733 | -2,064 | -1,925 | -2,370 | -5,202 | -5,468 | -4,334 | -4,608 | -2,958 | -2,192 | -387 | -1,130 | -4,273 | -4,873 | -6,322 | -4,592 | -3,299 |
Share Based Compensation | - | - | - | - | - | - | - | - | - | 292 | 505 | 491 | 356 | 203 | 249 | 509 | 419 | 430 | 543 | 436 | 1,860 | 19.00 |
Cashflow From Investing | 102.5% | 5.00 | -184 | -120 | -102 | 1,102 | -177 | 96.00 | -410 | -142 | -231 | -2,030 | 455 | -1,423 | 447 | 282 | -55.40 | -1,240 | -555 | -527 | -246 | -92.48 |
Cashflow From Financing | 52079.2% | 1,300 | -2.50 | -665 | 1,471 | -1,002 | -1,125 | -1,003 | -1,001 | -1,015 | -1,015 | 13,792 | -574 | -669 | 15,685 | -76.07 | 1,356 | 16,689 | 4,401 | -93.95 | 11,833 | - |
Dividend Payments | - | - | - | - | - | - | - | - | - | 1,001 | 1,001 | 1,334 | 560 | 560 | 100 | 100 | 100 | 100 | 67.00 | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
Gross Sales | $ 4,816,444 | $ 6,584,666 | $ 10,192,075 | $ 12,825,191 |
Allowances | (439,926) | (344,646) | (440,152) | (499,954) |
Total Net Sales | 4,376,518 | 6,240,020 | 9,751,923 | 12,325,237 |
Cost of sales | 1,795,790 | 2,224,512 | 3,613,698 | 4,741,964 |
Gross Profit | 2,580,728 | 4,015,508 | 6,138,225 | 7,583,273 |
Operating expenses | 4,131,719 | 5,416,151 | 8,755,053 | 13,030,097 |
Loss from operations | (1,550,991) | (1,400,643) | (2,616,828) | (5,446,824) |
(Increase) decrease of contingent liability | 4,828 | 48,000 | 74,580 | 109,000 |
(Increase) decrease in fair value of convertible debt | (1,446,000) | 0 | (1,446,000) | 0 |
Other income | 0 | 17,787 | 0 | 49,543 |
Interest expense | (18,399) | (1,946) | (18,817) | (4,583) |
Loss before provision for income taxes | (3,010,562) | (1,336,802) | (4,007,065) | (5,292,864) |
Net Loss | (3,010,562) | (1,336,802) | (4,007,065) | (5,292,864) |
Preferred dividends | 1,000,500 | 1,000,500 | 2,001,000 | 2,001,002 |
Net Loss attributable to cbdMD, Inc. common shareholders | $ (4,011,062) | $ (2,337,302) | $ (6,008,065) | $ (7,293,866) |
Net Loss per share: | ||||
Basic earnings per share (in dollars per share) | $ (1.35) | $ (1.74) | $ (2.03) | $ (5.43) |
Diluted earnings per share (in dollars per share) | $ (1.35) | $ (1.74) | $ (2.03) | $ (5.43) |
Weighted average number of shares Basic: (in shares) | 2,961,057 | 1,345,589 | 2,961,000 | 1,343,394 |
Weighted average number of shares Diluted: (in shares) | 2,961,057 | 1,345,589 | 2,961,000 | 1,343,394 |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2024 | Sep. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,105,396 | $ 1,797,860 |
Accounts receivable, net of allowance for credit losses of $179,419 and $42,180, respectively | 868,217 | 1,216,090 |
Inventory | 3,174,005 | 4,052,972 |
Inventory prepaid | 277,794 | 182,675 |
Prepaid sponsorship | 52,078 | 70,061 |
Prepaid expenses and other current assets | 932,770 | 750,383 |
Total current assets | 7,410,260 | 8,070,041 |
Other assets: | ||
Property and equipment, net | 667,979 | 716,579 |
Operating lease assets | 2,766,290 | 3,350,865 |
Deposits for facilities | 132,203 | 138,708 |
Intangible assets | 2,873,406 | 3,219,090 |
Investment in other securities, noncurrent | 700,000 | 700,000 |
Total other assets | 7,139,878 | 8,125,242 |
Total assets | 14,550,138 | 16,195,283 |
Current liabilities: | ||
Accounts payable | 1,291,306 | 1,906,319 |
Accrued expenses | 1,282,028 | 629,648 |
Accrued dividends | 2,668,000 | 667,000 |
Deferred revenue | 468,472 | 187,793 |
Operating leases – current portion | 1,226,764 | 1,277,089 |
Note payable | 0 | 2,492 |
Total current liabilities | 6,936,570 | 4,670,341 |
Long term liabilities: | ||
Convertible notes | 2,702,000 | 0 |
Other long term liabilities | 0 | 9 |
Operating leases - long term portion | 1,824,721 | 2,403,286 |
Contingent liability | 0 | 90,363 |
Total long term liabilities | 4,526,721 | 2,493,658 |
Total liabilities | 11,463,291 | 7,163,999 |
Commitments and Contingencies (Note 11) | ||
cbdMD, Inc. shareholders' equity: | ||
Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 5,000,000 shares issued and outstanding, respectively | 5,000 | 5,000 |
Common stock, authorized 150,000,000 shares, $0.001 par value, 3,045,204 and 2,960,573 shares issued and outstanding, respectively | 3,045 | 2,961 |
Additional paid in capital | 183,456,639 | 183,387,095 |
Comprehensive other expense | (6,000) | 0 |
Accumulated deficit | (180,371,836) | (174,363,772) |
Total cbdMD, Inc. shareholders' equity | 3,086,847 | 9,031,284 |
Total liabilities and shareholders' equity | $ 14,550,138 | $ 16,195,283 |
 | Mr. T. Ronan Kennedy |
---|---|
 | cbdmd.com |
 | Pharmaceuticals |
 | 90 |